NextCompany

$1.1 Million EBITDA, Electrotherapy TENS Device Company in Texas

Texas TENS Device Company with 84 Percent Revenue CAGR

On NextCompany since August 27, 2026 (48 days)

TX area
Financial summary
Asking price
$9,000,000
Gross revenue
$2,900,000
Cash flow (SDE)
N/A
EBITDA
$1,100,000

Figures come from the listing party and are not verified or guaranteed by NextCompany. Parts of this page are AI-generated and may contain errors. Verify everything before relying on it. See the Buyer Terms.

Business overview

The medical device company supplies non-invasive electrotherapy products in Texas. Product mix consists of 90 percent electrodes, 5 percent TENS devices, and 5 percent braces. Payer mix is 100 percent commercial insurance. Revenue grew at 84 percent CAGR over three years. The 2026 forecast projects $2,900,000 revenue and $1,100,000 adjusted EBITDA. Team of 8 employees and 7 contractors will stay. Asking price is $9,000,000 plus earn-out.

Who is a good fit for this business

  • Buyers targeting durable medical equipment companies with commercial insurance payer mix.
  • Acquirers seeking businesses with physician and therapist referral networks.
  • Investors interested in Texas-based device firms with 38 percent projected EBITDA margin.

Details

Frequently Asked Questions

Product mix consists of 90 percent electrodes, 5 percent TENS devices, and 5 percent braces. Payer mix is 100 percent commercial insurance. Physician and therapist referral network supports recurring revenue.

Revenue grew at 84 percent CAGR over three years. The 2026 forecast projects $2,900,000 revenue and $1,100,000 adjusted EBITDA. Team of 8 employees and 7 contractors will stay.

Asking price is $9,000,000 plus earn-out.

Similar businesses